PM Society names pharma prize finalists
pharmafile | December 17, 2014 | News story | Medical Communications, Sales and Marketing | GSK, Mundipharma, Shire, VCCP Health, digital awards, pm society
The finalists for the PM Society Awards have been announced today as pharma and med comms agencies gear up to see who was the best of the best in 2014.
Now in its 29th year, the awards which are to be held on 30 January will be spread across 19 categories and featured at Grosvenor House in London on the big day.
PM Society Awards chairman Neil Smith says: “It was fantastic to see the number of entries up at the same level as last year and we believe that the changes we’ve made to the categories and judging process reflect changes we are seeing in the industry.
Mundipharma tops the table of shortlisted entries for this year’s awards, with 13 projects reaching the finals. They are closely followed by Shire with 11. Joint third goes to GlaxoSmithKline and Fresenius Kabi with six finalist places each, and Sanofi Pasteur MSD has five projects in the running.
There are 33 other client companies represented amongst the finalists including AbbVie and Internis with four each and Takeda, Novo Nordisk and Napp with three.
Leading the agency board is VCCP Health with 14 submissions reaching the finals. In second position is HAVAS LYNX with nine shortlisted entries and in third Havas Life Medicom with seven.
McCann Health and McCann Manchester have six entries each at the final stages and Bedgebury Communications, bmore creative and inVentiv Health all have five.
These companies are among 28 agencies who will be battling it out at the event which this year has also seen some changes. Many categories were open to both digital and traditional media – so for the first time print detail aids are being judged against digital sales aids in the same category.
Also seeing its debut is the acceptance of international entries across the board. This year there are separate awards for house promotion and corporate communications as well as two patient awards covering disease awareness and patient support.
Another first (along with the dropping of ‘Advertising’ from the awards title) is the addition of a category for work created for events and exhibitions.
Smith adds: “We are very proud to be in our 29th year and expect another big turnout at Grosvenor House on 30 January”.
Brett Wells
Related Content
GSK’s Jemperli accepted for FDA review for endometrial cancer treatment
GSK has announced that the US Food and Drug Administration (FDA) has accepted its supplemental …
GSK shares results from phase 3 trial for gonorrhoea treatment
GSK has announced positive results from its phase 3 EAGLE-1 trial for gepotidacin, a potential …
GSK’s meningococcal vaccine candidate accepted for FDA review
GSK has announced that the US Food and Drug Administration (FDA) has accepted for review …
